These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1941627)

  • 1. Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells.
    Hammond JR
    J Pharmacol Exp Ther; 1991 Nov; 259(2):799-807. PubMed ID: 1941627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential uptake of [3H]guanosine by nucleoside transporter subtypes in Ehrlich ascites tumour cells.
    Hammond JR
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):431-6. PubMed ID: 1445201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
    Hammond JR
    Mol Pharmacol; 1991 Jun; 39(6):771-9. PubMed ID: 2051991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional reconstitution of pharmacologically distinct subtypes of nucleoside transporters in liposomal membranes.
    Hammond JR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):906-17. PubMed ID: 7965812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of detergents on ligand binding and translocation activities of solubilized/reconstituted nucleoside transporters.
    Hammond JR; Zarenda M
    Arch Biochem Biophys; 1996 Aug; 332(2):313-22. PubMed ID: 8806740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
    Belt JA
    Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.
    Burke T; Lee S; Ferguson PJ; Hammond JR
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells.
    Cory JG; Downes DL; Ng CY; Belt JA
    Oncol Res; 1992; 4(4-5):175-9. PubMed ID: 1504377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
    Plagemann PG; Woffendin C
    Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive and carrier-mediated permeation of different nucleosides through the reconstituted nucleoside transporter.
    Tse CM; Young JD
    Biochim Biophys Acta; 1989 Nov; 985(3):343-6. PubMed ID: 2804116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Ishimoto A; Fujimoto S
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):512-8. PubMed ID: 12679883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
    Jarvis SM
    Mol Pharmacol; 1986 Dec; 30(6):659-65. PubMed ID: 3785142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
    White JC; Hines LH
    Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters.
    Jarvis SM; Thorn JA; Glue P
    Br J Pharmacol; 1998 Apr; 123(8):1587-92. PubMed ID: 9605565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of HL-60 cells by dimethylsulfoxide activates a Na(+)-dependent nucleoside transport system.
    Lee CW; Sokoloski JA; Sartorelli AC; Handschumacher RE
    In Vivo; 1994; 8(5):795-801. PubMed ID: 7727727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of nucleoside transport systems in mammalian cells by a new series of compounds related to lidoflazine and mioflazine.
    Griffith DA; Conant AR; Jarvis SM
    Biochem Pharmacol; 1990 Nov; 40(10):2297-303. PubMed ID: 2244931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and reconstitution of a nucleoside-transport system from Ehrlich ascites-tumour cells.
    Hammond JR; Johnstone RM
    Biochem J; 1989 Aug; 262(1):109-18. PubMed ID: 2818557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells.
    Borgland SL; Parkinson FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):347-53. PubMed ID: 9103516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
    Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
    Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity.
    Smith PG; Thomas HD; Barlow HC; Griffin RJ; Golding BT; Calvert AH; Newell DR; Curtin NJ
    Clin Cancer Res; 2001 Jul; 7(7):2105-13. PubMed ID: 11448930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.